El fondo de ojo en la hipertension arterial
Qué es la HTA para el público en general
Déficit de lipasa acida lisosomal
Papel de la atención primaria de salud en el manejo de las enfermedades minoritarias raras
Día Mundial de las Enfermedades Minoritarias 2017 INCLIVA
Hipertesión y Farmacia Comunitaria en el siglo XXI
Manejo práctico de los inhibidores del CPKS9
Home enzymatic therapy administration for gaucher disease in spain
Home enzymatic infusion program for Gaucher and Fabry diseases. Economic impact evaluation of the experience in the Comunitat Valenciana in Spain.
Qualitative evaluation of the Home Therapy administration of enzymatic treatment for patients with Gaucher and Fabry disease in the Comunitat Valenciana in Spain
Home enzymatic therapy administration program for lysosomal diseases in Spain: first national experience.
Proposal of a tool for the assessment of the quality of Gaucher disease clinical management.
